A Resource for Healthcare and Social Services Professionals
May 31, 2022
8:00 am–8:30 am ET
This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.
Via Zoom
AUD Series: These trainings will provide an overview of alcohol use disorders, evidence-based screening tools, brief negotiated interview (BNI) for alcohol consumption, management of AUD in the primary care setting, and medications for the treatment of alcohol use disorder.
This training will review the basic pharmacology and clinical uses for both acamprosate and disulfiram in the treatment of alcohol use disorders.
Nurses, social workers, other clinical staff, and non-clinicians.
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
Boston Medical Center grants 0.50 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
